Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Stomach / Gastroesophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02943603
What this trial is testing

Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach

Who this might be right for
AdenocarcinomaStomach Cancer
Weijing Sun, MD, FACP
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Testing effectiveness (Phase 2)Study completedNCT01611857
What this trial is testing

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

Who this might be right for
Malignant Solid TumourGastroesophageal Cancer
SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Looking for participantsNCT06587425
What this trial is testing

The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02589496
What this trial is testing

Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Samsung Medical Center 80
Early research (Phase 1)Looking for participantsNCT07462923
What this trial is testing

HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Hansoh BioMedical R&D Company 40
Testing effectiveness (Phase 2)WithdrawnNCT03307941
What this trial is testing

Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionSquamous Cell Carcinoma of the Esophagus
Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT04727151
What this trial is testing

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerMetastatic HER2 Positive Gastroesophageal Junction Cancer
Triumvira Immunologics, Inc. 28
Early research (Phase 1)UnknownNCT05393986
What this trial is testing

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors

Who this might be right for
Gastric AdenocarcinomaPancreatic CancerGastroesophageal Junction Adenocarcinoma
Peking University 63
Testing effectiveness (Phase 2)Ended earlyNCT01123473
What this trial is testing

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionGastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07677293
What this trial is testing

Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases

Who this might be right for
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Peking University 332
Testing effectiveness (Phase 2)Active Not RecruitingNCT03776487
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

Who this might be right for
Clinical Stage 0 Gastric Cancer AJCC v8Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+25 more
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT06914687
What this trial is testing

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaPeritoneal Metastasis
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT03196232
What this trial is testing

Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaRecurrent Esophageal Carcinoma+4 more
George Albert Fisher 3
Testing effectiveness (Phase 2)Ended earlyNCT00098527
What this trial is testing

FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the StomachRecurrent Esophageal Cancer+1 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Looking for participantsNCT07284186
What this trial is testing

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Esophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastric Squamous Cell Carcinoma+7 more
Plexium, Inc. 155
Early research (Phase 1)UnknownNCT05315830
What this trial is testing

HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric

Who this might be right for
Adenocarcinoma - GEJAdenocarcinoma of the Stomach
The First Affiliated Hospital of Bengbu Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06808971
What this trial is testing

Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 61
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06942767
What this trial is testing

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Qilu Pharmaceutical Co., Ltd. 100
Next Page